Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3960 | 746 | 37.5 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
269 | 3 | CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE | 44007 |
3960 | 2 | IMP3//DLC1//DELETED IN LIVER CANCER 1 | 746 |
23000 | 1 | DLC1//DELETED IN LIVER CANCER 1//DLC 1 | 362 |
25169 | 1 | IMP3//CRD BP//KOC | 289 |
35582 | 1 | RASGAP//G3BP1//G3BP | 95 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IMP3 | authKW | 1894166 | 9% | 69% | 67 |
2 | DLC1 | authKW | 1182062 | 5% | 76% | 38 |
3 | DELETED IN LIVER CANCER 1 | authKW | 575587 | 2% | 94% | 15 |
4 | DLC 1 | authKW | 563279 | 2% | 81% | 17 |
5 | CRD BP | authKW | 534827 | 2% | 93% | 14 |
6 | CTEN | authKW | 532100 | 2% | 100% | 13 |
7 | KOC | authKW | 510049 | 2% | 69% | 18 |
8 | TENSIN | authKW | 399304 | 3% | 49% | 20 |
9 | IGF2BP1 | authKW | 392930 | 2% | 80% | 12 |
10 | IGF2BP3 | authKW | 380967 | 1% | 85% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2908 | 33% | 0% | 247 |
2 | Cell Biology | 1965 | 27% | 0% | 203 |
3 | Pathology | 1697 | 14% | 0% | 104 |
4 | Biochemistry & Molecular Biology | 576 | 26% | 0% | 195 |
5 | Genetics & Heredity | 411 | 11% | 0% | 82 |
6 | Developmental Biology | 136 | 3% | 0% | 23 |
7 | Veterinary Sciences | 133 | 6% | 0% | 43 |
8 | Gastroenterology & Hepatology | 58 | 3% | 0% | 26 |
9 | Medical Laboratory Technology | 49 | 2% | 0% | 12 |
10 | Medicine, Research & Experimental | 42 | 4% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TISSUE REGENERAT REPAIR | 138112 | 2% | 19% | 18 |
2 | UNIT ANAT CELL BIOL | 116551 | 2% | 19% | 15 |
3 | EXPT CARCINOGENESIS | 101013 | 4% | 7% | 33 |
4 | SECT BIOL SAFETY | 77128 | 1% | 27% | 7 |
5 | CHITOSE | 71618 | 1% | 25% | 7 |
6 | SH HO FDN | 61393 | 0% | 50% | 3 |
7 | TUMOR ANTIGEN DISCOVERY | 46043 | 0% | 38% | 3 |
8 | AFFILIATED HOSP CANC 2 RADIAT ONCOL | 40931 | 0% | 100% | 1 |
9 | BIOL LILLE UMR8161 | 40931 | 0% | 100% | 1 |
10 | BSBS ANTIBODY IL | 40931 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VETERINARY MEDICAL SCIENCE | 3995 | 3% | 0% | 26 |
2 | HUMAN PATHOLOGY | 2475 | 3% | 0% | 22 |
3 | ONCOGENE | 2281 | 4% | 0% | 32 |
4 | TOXICOLOGIC PATHOLOGY | 1593 | 1% | 0% | 10 |
5 | EXPERIMENTAL ANIMALS | 850 | 1% | 0% | 6 |
6 | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 680 | 1% | 0% | 5 |
7 | ONCOTARGET | 631 | 2% | 0% | 14 |
8 | INTERNATIONAL JOURNAL OF ONCOLOGY | 599 | 2% | 0% | 12 |
9 | MOLECULAR CANCER RESEARCH | 539 | 1% | 0% | 5 |
10 | MODERN PATHOLOGY | 534 | 1% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IMP3 | 1894166 | 9% | 69% | 67 | Search IMP3 | Search IMP3 |
2 | DLC1 | 1182062 | 5% | 76% | 38 | Search DLC1 | Search DLC1 |
3 | DELETED IN LIVER CANCER 1 | 575587 | 2% | 94% | 15 | Search DELETED+IN+LIVER+CANCER+1 | Search DELETED+IN+LIVER+CANCER+1 |
4 | DLC 1 | 563279 | 2% | 81% | 17 | Search DLC+1 | Search DLC+1 |
5 | CRD BP | 534827 | 2% | 93% | 14 | Search CRD+BP | Search CRD+BP |
6 | CTEN | 532100 | 2% | 100% | 13 | Search CTEN | Search CTEN |
7 | KOC | 510049 | 2% | 69% | 18 | Search KOC | Search KOC |
8 | TENSIN | 399304 | 3% | 49% | 20 | Search TENSIN | Search TENSIN |
9 | IGF2BP1 | 392930 | 2% | 80% | 12 | Search IGF2BP1 | Search IGF2BP1 |
10 | IGF2BP3 | 380967 | 1% | 85% | 11 | Search IGF2BP3 | Search IGF2BP3 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BELL, JL , WACHTER, K , MULECK, B , PAZAITIS, N , KOHN, M , LEDERER, M , HUTTELMAIER, S , (2013) INSULIN-LIKE GROWTH FACTOR 2 MRNA-BINDING PROTEINS (IGF2BPS): POST-TRANSCRIPTIONAL DRIVERS OF CANCER PROGRESSION?.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 70. ISSUE 15. P. 2657-2675 | 97 | 67% | 76 |
2 | LEDERER, M , BLEY, N , SCHLEIFER, C , HUTTELMAIER, S , (2014) THE ROLE OF THE ONCOFETAL IGF2 MRNA-BINDING PROTEIN 3 (IGF2BP3) IN CANCER.SEMINARS IN CANCER BIOLOGY. VOL. 29. ISSUE . P. 3 -12 | 93 | 76% | 15 |
3 | FINDEIS-HOSEY, JJ , XU, HD , (2011) THE USE OF INSULIN LIKE-GROWTH FACTOR II MESSENGER RNA BINDING PROTEIN-3 IN DIAGNOSTIC PATHOLOGY.HUMAN PATHOLOGY. VOL. 42. ISSUE 3. P. 303-314 | 49 | 89% | 30 |
4 | KO, FCF , YAM, JW , (2014) REGULATION OF DELETED IN LIVER CANCER 1 TUMOR SUPPRESSOR BY PROTEIN-PROTEIN INTERACTIONS AND PHOSPHORYLATION.INTERNATIONAL JOURNAL OF CANCER. VOL. 135. ISSUE 2. P. 264-269 | 42 | 93% | 6 |
5 | BRAUN, AC , OLAYIOYE, MA , (2015) RHO REGULATION: DLC PROTEINS IN SPACE AND TIME.CELLULAR SIGNALLING. VOL. 27. ISSUE 8. P. 1643 -1651 | 55 | 58% | 10 |
6 | POPESCU, NC , GOODISON, S , (2014) DELETED IN LIVER CANCER-1 (DLC1): AN EMERGING METASTASIS SUPPRESSOR GENE.MOLECULAR DIAGNOSIS & THERAPY. VOL. 18. ISSUE 3. P. 293 -302 | 52 | 63% | 5 |
7 | BARRAS, D , WIDMANN, C , (2014) GAP-INDEPENDENT FUNCTIONS OF DLC1 IN METASTASIS.CANCER AND METASTASIS REVIEWS. VOL. 33. ISSUE 1. P. 87 -100 | 62 | 48% | 6 |
8 | GONG, Y , WODA, BA , JIANG, Z , (2014) ONCOFETAL PROTEIN IMP3, A NEW CANCER BIOMARKER.ADVANCES IN ANATOMIC PATHOLOGY. VOL. 21. ISSUE 3. P. 191-200 | 44 | 64% | 7 |
9 | CHISTE, M , ALEXIS, J , RECINE, M , (2014) IMP3 EXPRESSION IN SEROUS TUMORS OF THE OVARY.APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. VOL. 22. ISSUE 9. P. 658 -662 | 34 | 85% | 1 |
10 | TRIPATHI, SC , KAUR, J , MATTA, A , GAO, X , SUN, B , CHAUHAN, SS , THAKAR, A , SHUKLA, NK , DUGGAL, R , CHOUDHARY, AR , ET AL (2012) LOSS OF DLC1 IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA.MODERN PATHOLOGY. VOL. 25. ISSUE 1. P. 14-25 | 39 | 70% | 7 |
Classes with closest relation at Level 2 |